nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanidine—SLC22A5—Dactinomycin—testicular cancer	0.137	0.408	CbGbCtD
Guanidine—SLC22A2—Vinblastine—testicular cancer	0.082	0.244	CbGbCtD
Guanidine—SLC22A2—Cisplatin—testicular cancer	0.0751	0.224	CbGbCtD
Guanidine—SLC22A8—Methotrexate—testicular cancer	0.0418	0.124	CbGbCtD
Guanidine—KCNH1—embryo—testicular cancer	0.0183	0.0451	CbGeAlD
Guanidine—GAMT—Podofilox—Etoposide—testicular cancer	0.0143	1	CbGdCrCtD
Guanidine—KCNG2—testis—testicular cancer	0.0139	0.0342	CbGeAlD
Guanidine—KCND1—embryo—testicular cancer	0.0135	0.0334	CbGeAlD
Guanidine—DLG4—seminal vesicle—testicular cancer	0.0133	0.0328	CbGeAlD
Guanidine—KCNS1—seminal vesicle—testicular cancer	0.0133	0.0328	CbGeAlD
Guanidine—KCNF1—seminal vesicle—testicular cancer	0.0109	0.0269	CbGeAlD
Guanidine—KCNS3—seminal vesicle—testicular cancer	0.00954	0.0236	CbGeAlD
Guanidine—Renal tubular necrosis—Ifosfamide—testicular cancer	0.0094	0.0385	CcSEcCtD
Guanidine—KCNV2—testis—testicular cancer	0.00937	0.0231	CbGeAlD
Guanidine—RNASE1—seminal vesicle—testicular cancer	0.00927	0.0229	CbGeAlD
Guanidine—KCND1—gonad—testicular cancer	0.0092	0.0227	CbGeAlD
Guanidine—GAMT—seminal vesicle—testicular cancer	0.00901	0.0222	CbGeAlD
Guanidine—KCNH1—testis—testicular cancer	0.00894	0.0221	CbGeAlD
Guanidine—KCNH3—testis—testicular cancer	0.00797	0.0197	CbGeAlD
Guanidine—KCNG1—testis—testicular cancer	0.00797	0.0197	CbGeAlD
Guanidine—DLG4—female gonad—testicular cancer	0.00781	0.0193	CbGeAlD
Guanidine—KCNH8—testis—testicular cancer	0.00771	0.019	CbGeAlD
Guanidine—KCNC3—testis—testicular cancer	0.00749	0.0185	CbGeAlD
Guanidine—KCNA5—gonad—testicular cancer	0.00704	0.0174	CbGeAlD
Guanidine—KCNQ1—seminal vesicle—testicular cancer	0.00702	0.0173	CbGeAlD
Guanidine—DLG4—testis—testicular cancer	0.00693	0.0171	CbGeAlD
Guanidine—KCNA2—testis—testicular cancer	0.00693	0.0171	CbGeAlD
Guanidine—KCNS1—testis—testicular cancer	0.00693	0.0171	CbGeAlD
Guanidine—KCNC4—testis—testicular cancer	0.00663	0.0164	CbGeAlD
Guanidine—KCND1—testis—testicular cancer	0.00663	0.0164	CbGeAlD
Guanidine—KCNC1—testis—testicular cancer	0.00637	0.0157	CbGeAlD
Guanidine—KCNH7—testis—testicular cancer	0.00637	0.0157	CbGeAlD
Guanidine—KCNQ4—testis—testicular cancer	0.00637	0.0157	CbGeAlD
Guanidine—KCNQ2—gonad—testicular cancer	0.00635	0.0157	CbGeAlD
Guanidine—Eruption—Dactinomycin—testicular cancer	0.00596	0.0244	CcSEcCtD
Guanidine—Folliculitis—Dactinomycin—testicular cancer	0.00583	0.0239	CcSEcCtD
Guanidine—KCNA5—female gonad—testicular cancer	0.00572	0.0141	CbGeAlD
Guanidine—RNASE1—female gonad—testicular cancer	0.00544	0.0134	CbGeAlD
Guanidine—KCNA3—lymph node—testicular cancer	0.00528	0.013	CbGeAlD
Guanidine—KCNQ2—female gonad—testicular cancer	0.00516	0.0127	CbGeAlD
Guanidine—KCNA5—testis—testicular cancer	0.00508	0.0125	CbGeAlD
Guanidine—KCNA2—lymph node—testicular cancer	0.00502	0.0124	CbGeAlD
Guanidine—DLG4—lymph node—testicular cancer	0.00502	0.0124	CbGeAlD
Guanidine—KCNS3—testis—testicular cancer	0.00497	0.0123	CbGeAlD
Guanidine—ALDH2—seminal vesicle—testicular cancer	0.0049	0.0121	CbGeAlD
Guanidine—KCND2—female gonad—testicular cancer	0.00489	0.0121	CbGeAlD
Guanidine—RNASE1—testis—testicular cancer	0.00483	0.0119	CbGeAlD
Guanidine—KCNC4—lymph node—testicular cancer	0.0048	0.0119	CbGeAlD
Guanidine—GAMT—testis—testicular cancer	0.00469	0.0116	CbGeAlD
Guanidine—KCNQ2—testis—testicular cancer	0.00458	0.0113	CbGeAlD
Guanidine—KCNQ5—lymph node—testicular cancer	0.00449	0.0111	CbGeAlD
Guanidine—Tubulointerstitial nephritis—Ifosfamide—testicular cancer	0.00439	0.018	CcSEcCtD
Guanidine—KCND2—testis—testicular cancer	0.00433	0.0107	CbGeAlD
Guanidine—KCNQ1—female gonad—testicular cancer	0.00412	0.0102	CbGeAlD
Guanidine—Petechiae—Ifosfamide—testicular cancer	0.00408	0.0167	CcSEcCtD
Guanidine—SLC22A4—seminal vesicle—testicular cancer	0.00382	0.00944	CbGeAlD
Guanidine—KCND3—testis—testicular cancer	0.00378	0.00932	CbGeAlD
Guanidine—SLC22A3—embryo—testicular cancer	0.0037	0.00914	CbGeAlD
Guanidine—KCNA5—lymph node—testicular cancer	0.00368	0.00908	CbGeAlD
Guanidine—KCNQ1—testis—testicular cancer	0.00366	0.00903	CbGeAlD
Guanidine—KCNS3—lymph node—testicular cancer	0.0036	0.00889	CbGeAlD
Guanidine—ALDH2—gonad—testicular cancer	0.00354	0.00873	CbGeAlD
Guanidine—RNASE1—lymph node—testicular cancer	0.0035	0.00863	CbGeAlD
Guanidine—SLC22A3—seminal vesicle—testicular cancer	0.00348	0.00859	CbGeAlD
Guanidine—Ataxia—Chlorambucil—testicular cancer	0.00347	0.0142	CcSEcCtD
Guanidine—GAMT—lymph node—testicular cancer	0.0034	0.0084	CbGeAlD
Guanidine—Azotaemia—Methotrexate—testicular cancer	0.00298	0.0122	CcSEcCtD
Guanidine—ALDH2—female gonad—testicular cancer	0.00287	0.00709	CbGeAlD
Guanidine—Body temperature increased—Carboplatin—testicular cancer	0.00278	0.0114	CcSEcCtD
Guanidine—KCND3—lymph node—testicular cancer	0.00274	0.00676	CbGeAlD
Guanidine—KCNH2—seminal vesicle—testicular cancer	0.00268	0.00661	CbGeAlD
Guanidine—KCNQ1—lymph node—testicular cancer	0.00265	0.00654	CbGeAlD
Guanidine—Eruption—Methotrexate—testicular cancer	0.00258	0.0106	CcSEcCtD
Guanidine—Atrial fibrillation—Ifosfamide—testicular cancer	0.00257	0.0105	CcSEcCtD
Guanidine—ALDH2—testis—testicular cancer	0.00255	0.00629	CbGeAlD
Guanidine—Hallucination—Chlorambucil—testicular cancer	0.00254	0.0104	CcSEcCtD
Guanidine—SLC22A5—seminal vesicle—testicular cancer	0.00253	0.00624	CbGeAlD
Guanidine—Folliculitis—Methotrexate—testicular cancer	0.00253	0.0103	CcSEcCtD
Guanidine—SLC22A3—gonad—testicular cancer	0.00251	0.0062	CbGeAlD
Guanidine—Liver function test abnormal—Dactinomycin—testicular cancer	0.00246	0.0101	CcSEcCtD
Guanidine—Eruption—Epirubicin—testicular cancer	0.00242	0.0099	CcSEcCtD
Guanidine—Psychotic disorder—Ifosfamide—testicular cancer	0.00238	0.00975	CcSEcCtD
Guanidine—Folliculitis—Epirubicin—testicular cancer	0.00237	0.00969	CcSEcCtD
Guanidine—Eruption—Doxorubicin—testicular cancer	0.00224	0.00916	CcSEcCtD
Guanidine—Folliculitis—Doxorubicin—testicular cancer	0.00219	0.00896	CcSEcCtD
Guanidine—Tremor—Chlorambucil—testicular cancer	0.00208	0.00851	CcSEcCtD
Guanidine—Anaemia—Chlorambucil—testicular cancer	0.00205	0.0084	CcSEcCtD
Guanidine—SLC22A3—female gonad—testicular cancer	0.00204	0.00504	CbGeAlD
Guanidine—Irritability—Cisplatin—testicular cancer	0.00201	0.00821	CcSEcCtD
Guanidine—Leukopenia—Chlorambucil—testicular cancer	0.00199	0.00813	CcSEcCtD
Guanidine—Petechiae—Methotrexate—testicular cancer	0.00193	0.00791	CcSEcCtD
Guanidine—Anaemia—Vinblastine—testicular cancer	0.00188	0.0077	CcSEcCtD
Guanidine—ALDH2—lymph node—testicular cancer	0.00185	0.00456	CbGeAlD
Guanidine—Flushing—Bleomycin—testicular cancer	0.00183	0.0075	CcSEcCtD
Guanidine—Confusional state—Chlorambucil—testicular cancer	0.00183	0.00748	CcSEcCtD
Guanidine—Leukopenia—Vinblastine—testicular cancer	0.00182	0.00745	CcSEcCtD
Guanidine—SLC22A3—testis—testicular cancer	0.00181	0.00447	CbGeAlD
Guanidine—Petechiae—Epirubicin—testicular cancer	0.00181	0.0074	CcSEcCtD
Guanidine—Thrombocytopenia—Chlorambucil—testicular cancer	0.00177	0.00726	CcSEcCtD
Guanidine—Anorexia—Chlorambucil—testicular cancer	0.00173	0.00707	CcSEcCtD
Guanidine—Flushing—Dactinomycin—testicular cancer	0.00171	0.00699	CcSEcCtD
Guanidine—Hallucination—Ifosfamide—testicular cancer	0.00168	0.00687	CcSEcCtD
Guanidine—Petechiae—Doxorubicin—testicular cancer	0.00167	0.00685	CcSEcCtD
Guanidine—Thrombocytopenia—Vinblastine—testicular cancer	0.00163	0.00665	CcSEcCtD
Guanidine—Anaemia—Bleomycin—testicular cancer	0.00159	0.0065	CcSEcCtD
Guanidine—Anorexia—Vinblastine—testicular cancer	0.00158	0.00648	CcSEcCtD
Guanidine—Decreased appetite—Chlorambucil—testicular cancer	0.00157	0.00645	CcSEcCtD
Guanidine—KCNH2—female gonad—testicular cancer	0.00157	0.00388	CbGeAlD
Guanidine—Flushing—Ifosfamide—testicular cancer	0.00157	0.00641	CcSEcCtD
Guanidine—Leukopenia—Bleomycin—testicular cancer	0.00154	0.0063	CcSEcCtD
Guanidine—Feeling abnormal—Chlorambucil—testicular cancer	0.00149	0.00611	CcSEcCtD
Guanidine—Paraesthesia—Vinblastine—testicular cancer	0.00149	0.0061	CcSEcCtD
Guanidine—SLC22A5—female gonad—testicular cancer	0.00149	0.00367	CbGeAlD
Guanidine—Anaemia—Dactinomycin—testicular cancer	0.00148	0.00606	CcSEcCtD
Guanidine—SLC22A4—lymph node—testicular cancer	0.00144	0.00356	CbGeAlD
Guanidine—Decreased appetite—Vinblastine—testicular cancer	0.00144	0.00591	CcSEcCtD
Guanidine—Ecchymosis—Methotrexate—testicular cancer	0.00144	0.00588	CcSEcCtD
Guanidine—Leukopenia—Dactinomycin—testicular cancer	0.00143	0.00587	CcSEcCtD
Guanidine—Abdominal pain—Chlorambucil—testicular cancer	0.00143	0.00586	CcSEcCtD
Guanidine—Body temperature increased—Chlorambucil—testicular cancer	0.00143	0.00586	CcSEcCtD
Guanidine—Confusional state—Bleomycin—testicular cancer	0.00141	0.00579	CcSEcCtD
Guanidine—KCNH2—testis—testicular cancer	0.00139	0.00344	CbGeAlD
Guanidine—Thrombocytopenia—Bleomycin—testicular cancer	0.00137	0.00562	CcSEcCtD
Guanidine—Feeling abnormal—Vinblastine—testicular cancer	0.00137	0.0056	CcSEcCtD
Guanidine—Anaemia—Ifosfamide—testicular cancer	0.00136	0.00556	CcSEcCtD
Guanidine—Flushing—Cisplatin—testicular cancer	0.00135	0.00552	CcSEcCtD
Guanidine—Ecchymosis—Epirubicin—testicular cancer	0.00134	0.0055	CcSEcCtD
Guanidine—Anorexia—Bleomycin—testicular cancer	0.00134	0.00547	CcSEcCtD
Guanidine—SLC22A5—testis—testicular cancer	0.00132	0.00325	CbGeAlD
Guanidine—Leukopenia—Ifosfamide—testicular cancer	0.00131	0.00538	CcSEcCtD
Guanidine—SLC22A3—lymph node—testicular cancer	0.00131	0.00324	CbGeAlD
Guanidine—Abdominal pain—Vinblastine—testicular cancer	0.00131	0.00537	CcSEcCtD
Guanidine—Hypotension—Bleomycin—testicular cancer	0.00131	0.00536	CcSEcCtD
Guanidine—Palpitations—Ifosfamide—testicular cancer	0.0013	0.00531	CcSEcCtD
Guanidine—Thrombocytopenia—Dactinomycin—testicular cancer	0.00128	0.00524	CcSEcCtD
Guanidine—Paraesthesia—Bleomycin—testicular cancer	0.00126	0.00515	CcSEcCtD
Guanidine—Anorexia—Dactinomycin—testicular cancer	0.00125	0.0051	CcSEcCtD
Guanidine—Ecchymosis—Doxorubicin—testicular cancer	0.00124	0.00509	CcSEcCtD
Guanidine—Diarrhoea—Chlorambucil—testicular cancer	0.00124	0.00507	CcSEcCtD
Guanidine—Flushing—Etoposide—testicular cancer	0.00124	0.00506	CcSEcCtD
Guanidine—Decreased appetite—Bleomycin—testicular cancer	0.00122	0.00499	CcSEcCtD
Guanidine—Confusional state—Ifosfamide—testicular cancer	0.00121	0.00495	CcSEcCtD
Guanidine—Vascular purpura—Epirubicin—testicular cancer	0.00121	0.00494	CcSEcCtD
Guanidine—Tremor—Cisplatin—testicular cancer	0.00119	0.00486	CcSEcCtD
Guanidine—Thrombocytopenia—Ifosfamide—testicular cancer	0.00117	0.0048	CcSEcCtD
Guanidine—Anaemia—Cisplatin—testicular cancer	0.00117	0.00479	CcSEcCtD
Guanidine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00116	0.00474	CcSEcCtD
Guanidine—Feeling abnormal—Bleomycin—testicular cancer	0.00116	0.00473	CcSEcCtD
Guanidine—Anorexia—Ifosfamide—testicular cancer	0.00114	0.00468	CcSEcCtD
Guanidine—Decreased appetite—Dactinomycin—testicular cancer	0.00114	0.00465	CcSEcCtD
Guanidine—Diarrhoea—Vinblastine—testicular cancer	0.00114	0.00465	CcSEcCtD
Guanidine—Leukopenia—Cisplatin—testicular cancer	0.00113	0.00464	CcSEcCtD
Guanidine—Purpura—Epirubicin—testicular cancer	0.00112	0.00458	CcSEcCtD
Guanidine—Hypotension—Ifosfamide—testicular cancer	0.00112	0.00458	CcSEcCtD
Guanidine—Vascular purpura—Doxorubicin—testicular cancer	0.00112	0.00457	CcSEcCtD
Guanidine—Body temperature increased—Bleomycin—testicular cancer	0.00111	0.00454	CcSEcCtD
Guanidine—Irritability—Methotrexate—testicular cancer	0.0011	0.00451	CcSEcCtD
Guanidine—Dizziness—Vinblastine—testicular cancer	0.0011	0.00449	CcSEcCtD
Guanidine—Mood swings—Methotrexate—testicular cancer	0.00109	0.00447	CcSEcCtD
Guanidine—Ataxia—Methotrexate—testicular cancer	0.00108	0.00444	CcSEcCtD
Guanidine—Feeling abnormal—Dactinomycin—testicular cancer	0.00108	0.00441	CcSEcCtD
Guanidine—Nausea—Chlorambucil—testicular cancer	0.00108	0.00441	CcSEcCtD
Guanidine—Paraesthesia—Ifosfamide—testicular cancer	0.00108	0.00441	CcSEcCtD
Guanidine—Anaemia—Etoposide—testicular cancer	0.00107	0.00439	CcSEcCtD
Guanidine—Liver function test abnormal—Methotrexate—testicular cancer	0.00106	0.00436	CcSEcCtD
Guanidine—Affect lability—Epirubicin—testicular cancer	0.00106	0.00435	CcSEcCtD
Guanidine—Decreased appetite—Ifosfamide—testicular cancer	0.00104	0.00426	CcSEcCtD
Guanidine—Leukopenia—Etoposide—testicular cancer	0.00104	0.00425	CcSEcCtD
Guanidine—Purpura—Doxorubicin—testicular cancer	0.00104	0.00424	CcSEcCtD
Guanidine—Abdominal pain—Dactinomycin—testicular cancer	0.00103	0.00423	CcSEcCtD
Guanidine—Body temperature increased—Dactinomycin—testicular cancer	0.00103	0.00423	CcSEcCtD
Guanidine—Mood swings—Epirubicin—testicular cancer	0.00102	0.00419	CcSEcCtD
Guanidine—Ataxia—Epirubicin—testicular cancer	0.00102	0.00416	CcSEcCtD
Guanidine—Thrombocytopenia—Cisplatin—testicular cancer	0.00101	0.00414	CcSEcCtD
Guanidine—KCNH2—lymph node—testicular cancer	0.00101	0.00249	CbGeAlD
Guanidine—Tachycardia—Cisplatin—testicular cancer	0.00101	0.00413	CcSEcCtD
Guanidine—Hyperhidrosis—Cisplatin—testicular cancer	0.000999	0.00409	CcSEcCtD
Guanidine—Liver function test abnormal—Epirubicin—testicular cancer	0.000997	0.00408	CcSEcCtD
Guanidine—Feeling abnormal—Ifosfamide—testicular cancer	0.000988	0.00404	CcSEcCtD
Guanidine—Nausea—Vinblastine—testicular cancer	0.000986	0.00404	CcSEcCtD
Guanidine—Anorexia—Cisplatin—testicular cancer	0.000985	0.00403	CcSEcCtD
Guanidine—Affect lability—Doxorubicin—testicular cancer	0.000983	0.00402	CcSEcCtD
Guanidine—Hypotension—Cisplatin—testicular cancer	0.000965	0.00395	CcSEcCtD
Guanidine—SLC22A5—lymph node—testicular cancer	0.000955	0.00236	CbGeAlD
Guanidine—Confusional state—Etoposide—testicular cancer	0.000954	0.00391	CcSEcCtD
Guanidine—Body temperature increased—Ifosfamide—testicular cancer	0.000947	0.00388	CcSEcCtD
Guanidine—Abdominal pain—Ifosfamide—testicular cancer	0.000947	0.00388	CcSEcCtD
Guanidine—Mood swings—Doxorubicin—testicular cancer	0.000946	0.00387	CcSEcCtD
Guanidine—Ataxia—Doxorubicin—testicular cancer	0.000939	0.00384	CcSEcCtD
Guanidine—Paraesthesia—Cisplatin—testicular cancer	0.000928	0.0038	CcSEcCtD
Guanidine—Thrombocytopenia—Etoposide—testicular cancer	0.000927	0.00379	CcSEcCtD
Guanidine—Tachycardia—Etoposide—testicular cancer	0.000924	0.00378	CcSEcCtD
Guanidine—Liver function test abnormal—Doxorubicin—testicular cancer	0.000922	0.00378	CcSEcCtD
Guanidine—Hyperhidrosis—Etoposide—testicular cancer	0.000915	0.00375	CcSEcCtD
Guanidine—Anorexia—Etoposide—testicular cancer	0.000902	0.00369	CcSEcCtD
Guanidine—Decreased appetite—Cisplatin—testicular cancer	0.000898	0.00368	CcSEcCtD
Guanidine—Diarrhoea—Dactinomycin—testicular cancer	0.000895	0.00366	CcSEcCtD
Guanidine—Hypotension—Etoposide—testicular cancer	0.000884	0.00362	CcSEcCtD
Guanidine—Rash—Bleomycin—testicular cancer	0.000884	0.00362	CcSEcCtD
Guanidine—Dermatitis—Bleomycin—testicular cancer	0.000883	0.00362	CcSEcCtD
Guanidine—Sweating—Methotrexate—testicular cancer	0.000852	0.00349	CcSEcCtD
Guanidine—Feeling abnormal—Cisplatin—testicular cancer	0.000851	0.00349	CcSEcCtD
Guanidine—Paraesthesia—Etoposide—testicular cancer	0.00085	0.00348	CcSEcCtD
Guanidine—Nausea—Bleomycin—testicular cancer	0.000833	0.00341	CcSEcCtD
Guanidine—Rash—Dactinomycin—testicular cancer	0.000825	0.00338	CcSEcCtD
Guanidine—Decreased appetite—Etoposide—testicular cancer	0.000823	0.00337	CcSEcCtD
Guanidine—Diarrhoea—Ifosfamide—testicular cancer	0.00082	0.00336	CcSEcCtD
Guanidine—Body temperature increased—Cisplatin—testicular cancer	0.000817	0.00334	CcSEcCtD
Guanidine—Sweating—Epirubicin—testicular cancer	0.000797	0.00326	CcSEcCtD
Guanidine—Dizziness—Ifosfamide—testicular cancer	0.000792	0.00324	CcSEcCtD
Guanidine—Feeling abnormal—Etoposide—testicular cancer	0.00078	0.00319	CcSEcCtD
Guanidine—Nausea—Dactinomycin—testicular cancer	0.000777	0.00318	CcSEcCtD
Guanidine—Rash—Ifosfamide—testicular cancer	0.000756	0.00309	CcSEcCtD
Guanidine—Dermatitis—Ifosfamide—testicular cancer	0.000755	0.00309	CcSEcCtD
Guanidine—Body temperature increased—Etoposide—testicular cancer	0.000748	0.00306	CcSEcCtD
Guanidine—Abdominal pain—Etoposide—testicular cancer	0.000748	0.00306	CcSEcCtD
Guanidine—Sweating—Doxorubicin—testicular cancer	0.000738	0.00302	CcSEcCtD
Guanidine—Nausea—Ifosfamide—testicular cancer	0.000712	0.00291	CcSEcCtD
Guanidine—Diarrhoea—Cisplatin—testicular cancer	0.000707	0.00289	CcSEcCtD
Guanidine—Flushing—Epirubicin—testicular cancer	0.000693	0.00284	CcSEcCtD
Guanidine—Rash—Cisplatin—testicular cancer	0.000651	0.00267	CcSEcCtD
Guanidine—Dermatitis—Cisplatin—testicular cancer	0.000651	0.00266	CcSEcCtD
Guanidine—Diarrhoea—Etoposide—testicular cancer	0.000648	0.00265	CcSEcCtD
Guanidine—Anaemia—Methotrexate—testicular cancer	0.000642	0.00263	CcSEcCtD
Guanidine—Flushing—Doxorubicin—testicular cancer	0.000641	0.00263	CcSEcCtD
Guanidine—Tension—Epirubicin—testicular cancer	0.000638	0.00261	CcSEcCtD
Guanidine—Nervousness—Epirubicin—testicular cancer	0.000631	0.00258	CcSEcCtD
Guanidine—Dizziness—Etoposide—testicular cancer	0.000626	0.00256	CcSEcCtD
Guanidine—Leukopenia—Methotrexate—testicular cancer	0.000622	0.00255	CcSEcCtD
Guanidine—Nausea—Cisplatin—testicular cancer	0.000614	0.00251	CcSEcCtD
Guanidine—Anaemia—Epirubicin—testicular cancer	0.000601	0.00246	CcSEcCtD
Guanidine—Rash—Etoposide—testicular cancer	0.000597	0.00244	CcSEcCtD
Guanidine—Dermatitis—Etoposide—testicular cancer	0.000596	0.00244	CcSEcCtD
Guanidine—Tension—Doxorubicin—testicular cancer	0.00059	0.00242	CcSEcCtD
Guanidine—Nervousness—Doxorubicin—testicular cancer	0.000584	0.00239	CcSEcCtD
Guanidine—Leukopenia—Epirubicin—testicular cancer	0.000582	0.00238	CcSEcCtD
Guanidine—Palpitations—Epirubicin—testicular cancer	0.000574	0.00235	CcSEcCtD
Guanidine—Confusional state—Methotrexate—testicular cancer	0.000572	0.00234	CcSEcCtD
Guanidine—Nausea—Etoposide—testicular cancer	0.000562	0.0023	CcSEcCtD
Guanidine—Anaemia—Doxorubicin—testicular cancer	0.000556	0.00228	CcSEcCtD
Guanidine—Thrombocytopenia—Methotrexate—testicular cancer	0.000555	0.00227	CcSEcCtD
Guanidine—Hyperhidrosis—Methotrexate—testicular cancer	0.000548	0.00224	CcSEcCtD
Guanidine—Dry mouth—Epirubicin—testicular cancer	0.000541	0.00222	CcSEcCtD
Guanidine—Anorexia—Methotrexate—testicular cancer	0.00054	0.00221	CcSEcCtD
Guanidine—Leukopenia—Doxorubicin—testicular cancer	0.000538	0.0022	CcSEcCtD
Guanidine—Confusional state—Epirubicin—testicular cancer	0.000535	0.00219	CcSEcCtD
Guanidine—Palpitations—Doxorubicin—testicular cancer	0.000532	0.00218	CcSEcCtD
Guanidine—Hypotension—Methotrexate—testicular cancer	0.00053	0.00217	CcSEcCtD
Guanidine—Thrombocytopenia—Epirubicin—testicular cancer	0.000519	0.00213	CcSEcCtD
Guanidine—Tachycardia—Epirubicin—testicular cancer	0.000518	0.00212	CcSEcCtD
Guanidine—Hyperhidrosis—Epirubicin—testicular cancer	0.000513	0.0021	CcSEcCtD
Guanidine—Paraesthesia—Methotrexate—testicular cancer	0.000509	0.00208	CcSEcCtD
Guanidine—Anorexia—Epirubicin—testicular cancer	0.000506	0.00207	CcSEcCtD
Guanidine—Dry mouth—Doxorubicin—testicular cancer	0.000501	0.00205	CcSEcCtD
Guanidine—Hypotension—Epirubicin—testicular cancer	0.000496	0.00203	CcSEcCtD
Guanidine—Confusional state—Doxorubicin—testicular cancer	0.000495	0.00203	CcSEcCtD
Guanidine—Decreased appetite—Methotrexate—testicular cancer	0.000493	0.00202	CcSEcCtD
Guanidine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000481	0.00197	CcSEcCtD
Guanidine—Tachycardia—Doxorubicin—testicular cancer	0.000479	0.00196	CcSEcCtD
Guanidine—Paraesthesia—Epirubicin—testicular cancer	0.000476	0.00195	CcSEcCtD
Guanidine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000475	0.00194	CcSEcCtD
Guanidine—Anorexia—Doxorubicin—testicular cancer	0.000468	0.00192	CcSEcCtD
Guanidine—Feeling abnormal—Methotrexate—testicular cancer	0.000467	0.00191	CcSEcCtD
Guanidine—Decreased appetite—Epirubicin—testicular cancer	0.000461	0.00189	CcSEcCtD
Guanidine—Hypotension—Doxorubicin—testicular cancer	0.000459	0.00188	CcSEcCtD
Guanidine—Body temperature increased—Methotrexate—testicular cancer	0.000448	0.00183	CcSEcCtD
Guanidine—Abdominal pain—Methotrexate—testicular cancer	0.000448	0.00183	CcSEcCtD
Guanidine—Paraesthesia—Doxorubicin—testicular cancer	0.000441	0.0018	CcSEcCtD
Guanidine—Feeling abnormal—Epirubicin—testicular cancer	0.000437	0.00179	CcSEcCtD
Guanidine—Decreased appetite—Doxorubicin—testicular cancer	0.000427	0.00175	CcSEcCtD
Guanidine—Body temperature increased—Epirubicin—testicular cancer	0.000419	0.00172	CcSEcCtD
Guanidine—Abdominal pain—Epirubicin—testicular cancer	0.000419	0.00172	CcSEcCtD
Guanidine—Feeling abnormal—Doxorubicin—testicular cancer	0.000405	0.00166	CcSEcCtD
Guanidine—Abdominal pain—Doxorubicin—testicular cancer	0.000388	0.00159	CcSEcCtD
Guanidine—Body temperature increased—Doxorubicin—testicular cancer	0.000388	0.00159	CcSEcCtD
Guanidine—Diarrhoea—Methotrexate—testicular cancer	0.000388	0.00159	CcSEcCtD
Guanidine—Dizziness—Methotrexate—testicular cancer	0.000375	0.00153	CcSEcCtD
Guanidine—Diarrhoea—Epirubicin—testicular cancer	0.000363	0.00149	CcSEcCtD
Guanidine—Rash—Methotrexate—testicular cancer	0.000357	0.00146	CcSEcCtD
Guanidine—Dermatitis—Methotrexate—testicular cancer	0.000357	0.00146	CcSEcCtD
Guanidine—Dizziness—Epirubicin—testicular cancer	0.000351	0.00144	CcSEcCtD
Guanidine—Nausea—Methotrexate—testicular cancer	0.000337	0.00138	CcSEcCtD
Guanidine—Diarrhoea—Doxorubicin—testicular cancer	0.000336	0.00138	CcSEcCtD
Guanidine—Rash—Epirubicin—testicular cancer	0.000335	0.00137	CcSEcCtD
Guanidine—Dermatitis—Epirubicin—testicular cancer	0.000334	0.00137	CcSEcCtD
Guanidine—Dizziness—Doxorubicin—testicular cancer	0.000325	0.00133	CcSEcCtD
Guanidine—Nausea—Epirubicin—testicular cancer	0.000315	0.00129	CcSEcCtD
Guanidine—Rash—Doxorubicin—testicular cancer	0.00031	0.00127	CcSEcCtD
Guanidine—Dermatitis—Doxorubicin—testicular cancer	0.000309	0.00127	CcSEcCtD
Guanidine—Nausea—Doxorubicin—testicular cancer	0.000292	0.00119	CcSEcCtD
